Moneycontrol
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Strides Pharma Science

Strides Pharma Science

BSE: 532531|NSE: STAR|ISIN: INE939A01011|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 19, 16:00
505.30
17.45 (3.58%)
VOLUME 128,906
LIVE
NSE
Feb 19, 15:59
505.25
17.35 (3.56%)
VOLUME 581,455
News on Strides Pharma Science
Select Year: 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Strides to acquire 18 abbreviated new drug applications from Pharmaceutics International, Inc

11.40 am | 07 Feb 2020 |  Source: PTI

"Strides...announced that its step-down wholly-owned subsidiary, Strides Pharma Global Pte Ltd, Singapore, has entered into a definitive asset transfe...

Strides Pharma share price gains 3% after co acquires 18 ANDAs for US market

11.12 am | 07 Feb 2020 |  Source: Moneycontrol.com

With access to these products, Strides Pharma will significantly expand its niche offerings on its front end, which has grown multi‐folds to attain ...

Strides Pharma Standalone December 2019 Net Sales at Rs 364.47 crore, down 12.11% Y-o-Y

12.30 pm | 31 Jan 2020 |  Source: Moneycontrol.com

NULL...

Strides Pharma Consolidated December 2019 Net Sales at Rs 732.44 crore, down 7.81% Y-o-Y

10.50 am | 31 Jan 2020 |  Source: Moneycontrol.com

NULL...

Strides Pharma Standalone December 2019 Net Sales at Rs 364.47 crore, down 12.11% Y-o-Y

2.18 pm | 30 Jan 2020 |  Source: Moneycontrol.com

NULL...

Strides Pharma Consolidated December 2019 Net Sales at Rs 732.44 crore, down 7.81% Y-o-Y

2.08 pm | 30 Jan 2020 |  Source: Moneycontrol.com

NULL...

Strides Pharma Science Q3 net declines 69% to Rs 92cr

12.52 pm | 30 Jan 2020 |  Source: PTI

However, the consolidated income of the company increased to Rs 744.66 crore in the October-December period, as against Rs 579.54 crore a year ago....

Strides Pharma share price up 7% after consolidated profit surges to Rs 101 crore

11.01 am | 30 Jan 2020 |  Source: Moneycontrol.com

Revenue was up 28 percent at Rs 735.3 crore versus Rs 573.8 crore, YoY while EBITDA jumped 184 percent to Rs 185.1 crore....

Strides Pharma Science Q3 profit rises 358%

9.59 am | 30 Jan 2020 |  Source: Moneycontrol.com

Earnings before interest, tax, depreciation and amortisation (EBITDA) was up 184 percent at Rs 185.1 crore against Rs 65 crore....

USFDA completes inspection of Strides Pharma's Alathur facility with zero observations

8.36 am | 25 Jan 2020 |  Source: PTI

The company's formulation facility at Alathur underwent a United States Food and Drug Administration (USFDA) inspection which concluded with '...

Strides arm receives EIR for its US facility

10.47 am | 20 Jan 2020 |  Source: PTI

Strides Pharma Inc received EIR from the United States Food and Drug Administration (USFDA) for the inspection conducted at its unit it December last ...

Strides gets USFDA nod for anti-allergic drug

10.38 am | 16 Jan 2020 |  Source: PTI

In a filing to BSE Strides said its "step-down wholly-owned subsidiary, Strides Pharma Global Pte Ltd, Singapore, has received approval for Loratadine...

Strides Pharma share price jumps 4% after Macquarie maintained outperform call

2.13 pm | 09 Jan 2020 |  Source: Moneycontrol.com

"Strides Pharma is one of our preferred picks in the midcap space," Macquarie said....

1 2
Quick Links for Strides Pharma Science
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.